Importance of Androgen regulated miRNAs in male fertility
雄激素调节的 miRNA 在男性生育能力中的重要性
基本信息
- 批准号:8889281
- 负责人:
- 金额:$ 7.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-15 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAndrogen ReceptorAndrogen Response ElementAndrogen SuppressionAndrogensApoptosisApplications GrantsBindingBiochemicalBiological AssayBlood TestsCell AdhesionCell Differentiation processCell physiologyCritical PathwaysDevelopmentDiseaseEventFertilityFoundationsGene TargetingGenesGenetic ModelsGenetic TranscriptionGerm CellsGiant CellsGoalsHealthIn VitroInfertilityKnock-outKnockout MiceMale ContraceptionsMalignant neoplasm of prostateMediatingMeiosisMessenger RNAMicroRNAsMolecularMusOligoribonucleotidesPathway interactionsPhagocytosisPhenocopyPhenotypePhysiologyPilot ProjectsPlayReproductive PhysiologyResearchRoleSiteSpermatidsSpermatocytesSpermatogenesisSyndromeTestingTestisTestosteroneTimeTrans-ActivatorsTranscriptTransgenic MiceTranslatingTranslationsUntranslated RNAWorkX Chromosomebasein vivoinsightmalemouse modelmutant mouse modelnovelnovel strategiesoverexpressionpromoterreproductivesertoli cell
项目摘要
DESCRIPTION (provided by applicant): Even after decades of research, the molecular basis for why spermatogenesis requires testosterone is not completely understood. This is in part because very few androgen-regulated genes have been definitively identified so far. It is likely that most androgen-regulated genes in the testis respond indirectly to androgen via activation or suppression of transcription by other trans-acting factors directly regulated by androgen. Recently, we have shown that one class of such androgen-regulated trans-acting factors in the testis are microRNAs (miRNAs), small non-coding RNA molecules that inhibit the translation of the target transcript by binding to complementary cis-regulatory sites in the mRNA. Specifically, we have shown that a number of these miRNAs are upregulated (suggesting their gene targets would be downregulated) in the absence of androgen. Our long term goal is to understand the in vivo function and mechanism by which these androgen-responsive miRNAs regulate critical pathways essential for male fertility. Toward this goal, we generated transgenic mice expressing miR-471 driven by the Sertoli cell-specific promoter Rhox5Pp that we have previously extensively characterized. Our preliminary analyses of miR-471 transgenic mice reveal that Sertoli cell-specific overexpression of miR-471 resulted in dramatically increased germ cell apoptosis, multinucleated giant cells suggesting abortive meiosis in spermatocytes, impaired postmeiotic germ cell differentiation and extensive germ cell sloughing, a phenotype that correlates with impaired Sertoli cell-Sertoli cell/germ cell adhesion at the blood-test barrier, which is an androgen-dependent event during spermatogenesis. These findings led us to hypothesize that by targeting specific transcripts, miR-471 expression in the Sertoli cells regulates specific androgen-dependent steps critical for germ cell development and progression. Two specific aims are proposed to test our hypothesis: In aim 1, we will extend our preliminary analysis and further characterize miR-471 transgenic mice. We will specifically assess the integrity of Sertoli cell-Sertoli cell/germ cell adhesion as well as germ cell meiotic arrest using molecular and biochemical approaches. This study will be highly significant as miR-471 transgenic mice represent the first genetic model to study the function of specific miRNAs in the Sertoli cells and miR-471 will be the first proven androgen-regulated miRNA important for male fertility. In aim 2, we will validate miR-471 gene targets and address their role in mediating
Sertoli cell-specific function of miR-471 using in vitro and ex-vivo approaches. The androgen-regulated miRNA on which this proposal is focused provide an opportunity to begin to address this. The proposed work will provide important leads to clearly understand the molecular mechanism by which androgen regulates critical pathways essential for male fertility. Furthermore, this research initiative may provide insights into the putative role of miRNA in androgen related diseases such as prostate cancer and androgen insufficiency syndrome.
描述(由申请人提供):即使经过几十年的研究,为什么精子发生需要睾酮的分子基础还没有完全被理解。这在一定程度上是因为到目前为止,很少有雄激素调节基因被明确识别出来。睾丸中大多数雄激素调节基因可能通过激活或抑制其他由雄激素直接调节的反式作用因子的转录来间接响应雄激素。最近,我们发现睾丸中一类雄激素调控的反式作用因子是microRNAs (miRNAs),这是一种小的非编码RNA分子,通过结合mRNA中互补的顺式调控位点来抑制目标转录物的翻译。具体来说,我们已经表明,在缺乏雄激素的情况下,这些mirna中的许多被上调(表明它们的基因靶标将被下调)。我们的长期目标是了解体内功能和机制,通过这些雄激素响应mirna调节关键途径至关重要的男性生育能力。为了实现这一目标,我们产生了表达miR-471的转基因小鼠,该小鼠由我们之前广泛表征的Sertoli细胞特异性启动子Rhox5Pp驱动。我们对miR-471转基因小鼠的初步分析显示,miR-471特异性过表达导致生殖细胞凋亡急剧增加,多核巨细胞提示精母细胞减数分裂流产,减数分裂后生殖细胞分化受损和广泛的生殖细胞脱落,这一表型与造血屏障上的支持细胞-支持细胞/生殖细胞粘附受损有关,这是精子发生过程中雄激素依赖的事件。这些发现使我们假设,通过靶向特异性转录本,miR-471在支持细胞中的表达调节了生殖细胞发育和进展中至关重要的特异性雄激素依赖步骤。我们提出了两个具体目标来验证我们的假设:在目标1中,我们将扩展我们的初步分析并进一步表征miR-471转基因小鼠。我们将使用分子和生化方法具体评估支持细胞-支持细胞/生殖细胞粘附的完整性以及生殖细胞减数分裂阻滞。这项研究将是非常重要的,因为miR-471转基因小鼠代表了第一个研究Sertoli细胞中特定miRNA功能的遗传模型,miR-471将是第一个被证明对男性生育能力重要的雄激素调节miRNA。在目标2中,我们将验证miR-471基因靶点并解决其在介导中的作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manjeet Kumar Rao其他文献
Manjeet Kumar Rao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manjeet Kumar Rao', 18)}}的其他基金
Novel approach of targeting AT-rich S/MAR regions for treating therapy resistant breast cancers
靶向富含 AT 的 S/MAR 区域治疗耐药性乳腺癌的新方法
- 批准号:
10744563 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers
FoXM1 抑制:治疗乳腺癌的新途径
- 批准号:
9897345 - 财政年份:2019
- 资助金额:
$ 7.29万 - 项目类别:
FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers
FoXM1 抑制:治疗乳腺癌的新途径
- 批准号:
10533268 - 财政年份:2019
- 资助金额:
$ 7.29万 - 项目类别:
FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers
FoXM1 抑制:治疗乳腺癌的新途径
- 批准号:
10304196 - 财政年份:2019
- 资助金额:
$ 7.29万 - 项目类别:
FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers
FoXM1 抑制:治疗乳腺癌的新途径
- 批准号:
10533572 - 财政年份:2019
- 资助金额:
$ 7.29万 - 项目类别:
FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers
FoXM1 抑制:治疗乳腺癌的新途径
- 批准号:
10737772 - 财政年份:2019
- 资助金额:
$ 7.29万 - 项目类别:
miRNAs:Safe and effective therapeutic adjuvants for treating drug resistant TNBC
miRNA:治疗耐药TNBC的安全有效的治疗佐剂
- 批准号:
9212787 - 财政年份:2015
- 资助金额:
$ 7.29万 - 项目类别:
Catenins: A role in spertmatogenesis and sperm maturation
连环蛋白:在精子发生和精子成熟中的作用
- 批准号:
7937735 - 财政年份:2009
- 资助金额:
$ 7.29万 - 项目类别:
Targeted Suppression of the Transcription Factor Sox9 in the Testis by Tissue-Spe
Tissue-Spe 靶向抑制睾丸中的转录因子 Sox9
- 批准号:
7263848 - 财政年份:2006
- 资助金额:
$ 7.29万 - 项目类别:
Targeted Suppression of the Transcription Factor Sox9
转录因子 Sox9 的靶向抑制
- 批准号:
7415283 - 财政年份:2006
- 资助金额:
$ 7.29万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




